We are live on ! Find out more
TPG GP A

TPG GP A Portfolio holdings

AUM $4.11B Turnover 25.27%
1-Year Est. Return 55.02%
This Fund
S&P 500
This Quarter Est. Return
+16.23%
1 Year Est. Return
+55.02%
3 Year Est. Return
+146.39%
5 Year Est. Return
+142.75%
10 Year Est. Return
–
AUM
$2.69B
AUM Growth
+$851M
Cap. Flow
+$489M
Cap. Flow %
18.21%
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
–
Reduced
–
Closed
–
Avg Time Held
2.7 years
Top 10 Avg Time Held
1.2 years
Top 20 Avg Time Held
1.3 years

Top Buys

Rank Stock Value
1
BETA icon
Beta Technologies
BETA
+$489M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 64.38%
2 Consumer Discretionary 17.64%
3 Industrials 17.22%
4 Real Estate 0.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
LFST icon
1
Lifestance Health
LFST
$5.24B
$1.13B 42.11%
160,711,618
– –
2021 Q4
16 quarters
LTH icon
2
Life Time Group Holdings
LTH
$10.8B
$474M 17.64%
17,830,652
– –
2021 Q4
16 quarters
BETA icon
3
Beta Technologies
BETA
$4.71B
$463M 17.22%
+16,395,435
New +$489M
2025 Q4
0 quarters
SION icon
4
Sionna Therapeutics
SION
$134M
$277M 10.33%
6,744,962
– –
2025 Q1
3 quarters
AMRX icon
5
Amneal Pharmaceuticals
AMRX
$7.62B
$155M 5.78%
12,328,767
– –
2021 Q4
16 quarters
CBLL icon
6
CeriBell
CBLL
$995M
$87M 3.24%
3,967,422
– –
2024 Q4
4 quarters
BCAX icon
7
Bicara Therapeutics
BCAX
$623M
$50.7M 1.89%
3,010,425
– –
2024 Q3
5 quarters
ALLO icon
8
Allogene Therapeutics
ALLO
$241M
$25.6M 0.95%
18,716,306
– –
2021 Q4
16 quarters
TRTX icon
9
TPG RE Finance Trust
TRTX
$491M
$20.6M 0.77%
2,392,863
– –
2021 Q4
16 quarters
RLYB icon
10
Rallybio
RLYB
$85.5M
$2.09M 0.08%
757,104
– –
2021 Q4
16 quarters

Similar funds

TPG GP A's Q4 2025 Portfolio in Review

As of Q4 2025, TPG GP A held 10 positions worth $2.69B, up 46% from $1.84B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

TPG GP A deployed $489M of net new capital in Q4 2025, opening 1 new position. Its largest new stake was Beta Technologies: 16,395,435 shares worth $463M.

By sector, the portfolio is most concentrated in Healthcare at 64% of assets, down from 72% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • TPG GP A's largest Q4 2025 buy was Beta Technologies: 16,395,435 shares worth $463M.
  • TPG GP A's ten largest holdings make up 100% of its $2.69B portfolio in Q4 2025.
  • TPG GP A opened 1 new position and closed 0 in Q4 2025.
  • TPG GP A's portfolio value rose 46% quarter-over-quarter to $2.69B.

Based on TPG GP A's 13F filing for Q4 2025, filed 13 Feb 2026.